Giessen Pulmonary Hypertension in Lung Cancer Registry
Recruiting · NCT04467333 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Giessen
View the official record on ClinicalTrials.gov →Interventions studied
All lung cancer patients.
What this trial is about
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patient with lung cancer at the University of Giessen lung Cancer Center.
Where it is running
1 location listed.
- University hospital Giessen - Giessen, Hesse, Germany